VcA/IgA抗体对鼻咽癌诊断价值及预后探讨──附106例分析

 本文总结106例鼻咽癌患者放疗前后VCA/IgA抗体检测结果。放疗前VCA/IgA抗体总阳性率为84.0%,T1-T4分别为50.0%,73.3%,85.4%和96.8%.放疗后，鼻咽原发灶和颈部淋巴结消失，原发灶消失及颈淋巴结残存，原发灶和颈淋巴部均残存，远处转移，VCA/IgA抗体滴复阳性率分别为44.8%,70.0%,80.0%,100.0%.消失组与残存及转移组有显着差异（P<0.05）.此结果表明VCA/IgA检测对鼻咽癌诊断和预后有-定意义。

Clinical significance of VCA/IgA antibody assay in the diagnosis and procnosis of nasopharyngeal carcinoma-An analysis of 106 cases

Patients with nasopharyngeal carcinoma were assayed by VCA/IgA antibody before radiotherapy. Altogether, 84.0% Patients were found positive to VCA/IgA antibody. The positive rates of VCA/IgA antibody in T1-T4 were 50. 0%, 73. 3%, 85. 4% and 96. 8%, respectively. At the end of radiotherapy, the positive rates of VCA/IgA antibody in patients with disappear of local nasopharynx and cervical lymph, disappear of local and remains of ccrvical lymph, remains of local and cervical lymph,distant metastases were 44. 8%, 70. 0%, 80. 0% and 100. 0%,respectively (P<0. 05). This results showed that VCA/IgA assay may be valuble to the diagnosis and prognosis of N P C.